Class I · High risk
Antica Farmacista Hand Sanitizer Ocean Citron
Chemical Contamination: product found to contain benzene
FDA Drug Recalls
98 recalls · Class I, newest first
Class I · High risk
PROPOFOL Injectable Emulsion
Presence of particulate matter
Class I · High risk
Banana Boat hair & scalp defense
Chemical contamination: presence of benzene
Class I · High risk
SANGTER Energy Supplement Capsules
Marketed Without An Approved NDA/ANDA: FDA analysis found the product to be tainted with sildenafil.
Class I · High risk
SUSTANGO (Pendenadril Tytrate Blend)
Marketed Without an Approved NDA/ANDA: Analytical testing showed the presence of tadalafil.
Class I · High risk
Walgreens
Microbial contamination of non-sterile products.
Class I · High risk
Walgreens
Microbial contamination of non-sterile products.
Class I · High risk
Topcare health
Microbial contamination of non-sterile products.
Class I · High risk
Swan
Microbial contamination of non-sterile products.
Class I · High risk
Rexall
Microbial contamination of non-sterile products.
Class I · High risk
P, magnesium citrate SALINE LAXATIVE
Microbial contamination of non-sterile products.
Class I · High risk
meijer
Microbial contamination of non-sterile products.
Class I · High risk
Kroger
Microbial contamination of non-sterile products.
Class I · High risk
EQUALINE magnesium citrate saline laxative
Microbial contamination of non-sterile products.
Class I · High risk
equate Magnesium Citrate
Microbial contamination of non-sterile products.
Class I · High risk
CVS Health
Microbial contamination of non-sterile products.
Class I · High risk
Propofol Injectable Emulsion
Presence of particulate matter: particulate identified as a beetle.
Class I · High risk
Insulin Glargine
Labeling: Missing label: Label missing from some prefilled pens.
Class I · High risk
Launch Sequence Aphrodisia Capsules
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I · High risk
Launch Sequence Euphoria Capsules
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I · High risk
Launch Sequence Capsules
Marketed Without An Approved NDA/ANDA: Product found to contain undeclared tadalafil, an ingredient found in FDA approved products for the treatment of male sexual enhancement, making this an unapproved drug.
Class I · High risk
Nifedipine WSP 0.2% Ointment
Subpotent and Superpotent Drug
Class I · High risk
Morphine Sulfate extended-Release Tablets
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Class I · High risk
Morphine Sulfate extended-Release Tablets
Labeling: Label Mix-up: bottles labeled as Morphine Sulfate 60 mg Extended-Release tablets contain Morphine Sulfate 30 mg Extended-Release tablets and bottles labeled as Morphine Sulfate 30 mg Extended-Release tablets may contain Morphine Sulfate 60 mg Extended-Release tablets.
Class I · High risk
CVS Health Magnesium Citrate SALINE LAXATIVE
Microbial Contamination of a Non-Sterile Products: Testing of product onfirmed the presence of Gluconacetobacter Liquefaciens